188 related articles for article (PubMed ID: 12885880)
1. Diminished RNA primer usage associated with the L74V and M184V mutations in the reverse transcriptase of human immunodeficiency virus type 1 provides a possible mechanism for diminished viral replication capacity.
Diallo K; Marchand B; Wei X; Cellai L; Götte M; Wainberg MA
J Virol; 2003 Aug; 77(16):8621-32. PubMed ID: 12885880
[TBL] [Abstract][Full Text] [Related]
2. Impaired rescue of chain-terminated DNA synthesis associated with the L74V mutation in human immunodeficiency virus type 1 reverse transcriptase.
Frankel FA; Marchand B; Turner D; Götte M; Wainberg MA
Antimicrob Agents Chemother; 2005 Jul; 49(7):2657-64. PubMed ID: 15980333
[TBL] [Abstract][Full Text] [Related]
3. Negative effect of the M184V mutation in HIV-1 reverse transcriptase on initiation of viral DNA synthesis.
Wei X; Liang C; Götte M; Wainberg MA
Virology; 2003 Jun; 311(1):202-12. PubMed ID: 12832217
[TBL] [Abstract][Full Text] [Related]
4. The M184V mutation in HIV-1 reverse transcriptase reduces the restoration of wild-type replication by attenuated viruses.
Wei X; Liang C; Götte M; Wainberg MA
AIDS; 2002 Dec; 16(18):2391-8. PubMed ID: 12461412
[TBL] [Abstract][Full Text] [Related]
5. Prevalence, genotypic associations and phenotypic characterization of K65R, L74V and other HIV-1 RT resistance mutations in a commercial database.
McColl DJ; Chappey C; Parkin NT; Miller MD
Antivir Ther; 2008; 13(2):189-97. PubMed ID: 18505170
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of resistance to human immunodeficiency virus type 1 with reverse transcriptase mutations K65R and K65R+M184V and their effects on enzyme function and viral replication capacity.
White KL; Margot NA; Wrin T; Petropoulos CJ; Miller MD; Naeger LK
Antimicrob Agents Chemother; 2002 Nov; 46(11):3437-46. PubMed ID: 12384348
[TBL] [Abstract][Full Text] [Related]
7. A Leu to Ile but not Leu to Val change at HIV-1 reverse transcriptase codon 74 in the background of K65R mutation leads to an increased processivity of K65R+L74I enzyme and a replication competent virus.
Chunduri H; Rimland D; Nurpeisov V; Crumpacker CS; Sharma PL
Virol J; 2011 Jan; 8():33. PubMed ID: 21255423
[TBL] [Abstract][Full Text] [Related]
8. Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication.
Naeger LK; Margot NA; Miller MD
Antivir Ther; 2001 Jun; 6(2):115-26. PubMed ID: 11491416
[TBL] [Abstract][Full Text] [Related]
9. Impact of human immunodeficiency virus type 1 reverse transcriptase inhibitor drug resistance mutation interactions on phenotypic susceptibility.
Trivedi V; Von Lindern J; Montes-Walters M; Rojo DR; Shell EJ; Parkin N; O'Brien WA; Ferguson MR
AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1291-300. PubMed ID: 18844463
[TBL] [Abstract][Full Text] [Related]
10. The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations.
Miranda LR; Götte M; Liang F; Kuritzkes DR
Antimicrob Agents Chemother; 2005 Jul; 49(7):2648-56. PubMed ID: 15980332
[TBL] [Abstract][Full Text] [Related]
11. A loss of viral replicative capacity correlates with altered DNA polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the K65R and L74V dideoxynucleoside resistance substitutions.
Deval J; Navarro JM; Selmi B; Courcambeck J; Boretto J; Halfon P; Garrido-Urbani S; Sire J; Canard B
J Biol Chem; 2004 Jun; 279(24):25489-96. PubMed ID: 15044478
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years.
Winters MA; Shafer RW; Jellinger RA; Mamtora G; Gingeras T; Merigan TC
Antimicrob Agents Chemother; 1997 Apr; 41(4):757-62. PubMed ID: 9087484
[TBL] [Abstract][Full Text] [Related]
13. Differential maintenance of the M184V substitution in the reverse transcriptase of human immunodeficiency virus type 1 by various nucleoside antiretroviral agents in tissue culture.
Petrella M; Oliveira M; Moisi D; Detorio M; Brenner BG; Wainberg MA
Antimicrob Agents Chemother; 2004 Nov; 48(11):4189-94. PubMed ID: 15504840
[TBL] [Abstract][Full Text] [Related]
14. Effect on HIV-1 viral replication capacity of DTG-resistance mutations in NRTI/NNRTI resistant viruses.
Pham HT; Mesplède T; Wainberg MA
Retrovirology; 2016 Apr; 13(1):31. PubMed ID: 27130466
[TBL] [Abstract][Full Text] [Related]
15. Diminished efficiency of HIV-1 reverse transcriptase containing the K65R and M184V drug resistance mutations.
Frankel FA; Invernizzi CF; Oliveira M; Wainberg MA
AIDS; 2007 Mar; 21(6):665-75. PubMed ID: 17413687
[TBL] [Abstract][Full Text] [Related]
16. The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis.
Götte M; Arion D; Parniak MA; Wainberg MA
J Virol; 2000 Apr; 74(8):3579-85. PubMed ID: 10729133
[TBL] [Abstract][Full Text] [Related]
17. Dominance of the E89G substitution in HIV-1 reverse transcriptase in regard to increased polymerase processivity and patterns of pausing.
Quan Y; Inouye P; Liang C; Rong L; Götte M; Wainberg MA
J Biol Chem; 1998 Aug; 273(34):21918-25. PubMed ID: 9705331
[TBL] [Abstract][Full Text] [Related]
18. Rationale for maintenance of the M184v resistance mutation in human immunodeficiency virus type 1 reverse transcriptase in treatment experienced patients.
Turner D; Brenner BG; Routy JP; Petrella M; Wainberg MA
New Microbiol; 2004 Apr; 27(2 Suppl 1):31-9. PubMed ID: 15646062
[TBL] [Abstract][Full Text] [Related]
19. Lamivudine can exert a modest antiviral effect against human immunodeficiency virus type 1 containing the M184V mutation.
Quan Y; Brenner BG; Oliveira M; Wainberg MA
Antimicrob Agents Chemother; 2003 Feb; 47(2):747-54. PubMed ID: 12543687
[TBL] [Abstract][Full Text] [Related]
20. Nucleotide substitutions within U5 are critical for efficient reverse transcription of human immunodeficiency virus type 1 with a primer binding site complementary to tRNA(His).
Li Y; Zhang Z; Wakefield JK; Kang SM; Morrow CD
J Virol; 1997 Sep; 71(9):6315-22. PubMed ID: 9261348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
